135 related articles for article (PubMed ID: 15316366)
1. Potent skin allograft survival prolongation using a committed progenitor fraction of bone marrow in mice.
Akpinar E; Craighead N; Smoot D; Hale DA
Transplantation; 2004 Aug; 78(3):383-91. PubMed ID: 15316366
[TBL] [Abstract][Full Text] [Related]
2. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
3. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
[TBL] [Abstract][Full Text] [Related]
4. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion.
Kanamoto A; Monaco AP; Maki T
Transplantation; 2004 Sep; 78(6):825-30. PubMed ID: 15385800
[TBL] [Abstract][Full Text] [Related]
5. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of renal allograft survival in antilymphocyte-serum-treated dogs by postoperative injection of density-gradient-fractionated donor bone marrow.
Hartner WC; De Fazio SR; Maki T; Markees TG; Monaco AP; Gozzo JJ
Transplantation; 1986 Dec; 42(6):593-7. PubMed ID: 2947358
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
[TBL] [Abstract][Full Text] [Related]
8. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
Fukuzaki T; Hancock WW; Monaco AP; Maki T
Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
[TBL] [Abstract][Full Text] [Related]
9. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
[TBL] [Abstract][Full Text] [Related]
10. Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow.
Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP
Transplantation; 2002 Aug; 74(4):477-84. PubMed ID: 12352905
[TBL] [Abstract][Full Text] [Related]
11. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
12. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
Jamshidi F; De Fazio SR; Gozzo JJ
Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
[TBL] [Abstract][Full Text] [Related]
13. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1997 Sep; 64(6):897-900. PubMed ID: 9326417
[TBL] [Abstract][Full Text] [Related]
14. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
Ohzato H; Monaco AP
Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
[TBL] [Abstract][Full Text] [Related]
15. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
[TBL] [Abstract][Full Text] [Related]
16. Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow.
Anam K; Akpinar E; Craighead N; Black AT; Hale DA
Transplantation; 2004 Nov; 78(9):1290-8. PubMed ID: 15548965
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
Pierce GE
Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
[TBL] [Abstract][Full Text] [Related]
18. Donor T cells are not required for induction of allograft tolerance in mice treated with antilymphocyte serum, rapamycin, and donor bone marrow cells.
Umemura A; Monaco AP; Maki T
Transplantation; 2000 Oct; 70(7):1005-9. PubMed ID: 11045634
[TBL] [Abstract][Full Text] [Related]
19. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
20. Requirement for early donor cell chimerism during prolonged survival of murine skin allografts.
Masli S; De Fazio SR; Gozzo JJ
Transplantation; 2000 Apr; 69(8):1667-75. PubMed ID: 10836379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
